Skip to main content
CAMBRIDGE NUTRITIONAL SCIENCES PLC logo

CAMBRIDGE NUTRITIONAL SCIENCES PLC — Investor Relations & Filings

Ticker · CNSL ISIN · GB00B1VCP282 LEI · 2138007U9P4BTZTYIR92 IL Manufacturing
Open in API
Filings indexed 532 across all filing types
Latest filing 2021-07-30 Report Publication Anno…
Country GB United Kingdom
Listing IL CNSL

About CAMBRIDGE NUTRITIONAL SCIENCES PLC

https://www.cnsplc.com/

Cambridge Nutritional Sciences PLC is a medical diagnostics company that develops, manufactures, and distributes products focused on promoting a personalised approach to health. The company specialises in a range of tests associated with food sensitivity and gut health. Utilising advanced diagnostic technology, its products are designed for use by healthcare professionals and their patients to identify potential food reactions and guide lifestyle and dietary changes. The company's goal is to enable individuals to improve their long-term health and wellbeing by understanding how their diet may be contributing to various health issues.

Recent filings

Filing Released Lang Actions
Posting of Annual Report & Accounts &Notice of AGM
Report Publication Announcement Classification · 1% confidence The document is a short announcement (under 5,000 characters) from Omega Diagnostics Group PLC stating that the Annual Report and Accounts and the Notice of AGM have been posted to shareholders and are available on the company's website. Per the 'Menu vs Meal' rule, this is an announcement of the availability of reports rather than the reports themselves, making it a Report Publication Announcement (RPA).
2021-07-30 English
AbC-19 monitors vaccine response to variants
Regulatory Filings Classification · 1% confidence The document is a press release distributed via the RNS Reach service, which is explicitly identified as a non-regulatory news service. It discusses the publication of a scientific article regarding the company's AbC-19 test. Since it does not fit into specific financial reporting categories like 10-K, ER, or IR, and serves as a general corporate announcement/press release, it falls under the RNS (Regulatory Filings) category as the designated fallback for miscellaneous announcements.
2021-07-27 English
Final Results
Annual Report Classification · 1% confidence The document is titled 'FINAL RESULTS FOR THE YEAR ENDED 31 MARCH 2021' and contains comprehensive financial highlights, a Chairman's Statement, a Chief Executive's Review, and detailed operational performance metrics for the full fiscal year. Although it is distributed via an RNS (Regulatory News Service) feed, it constitutes the actual annual financial results and management discussion for the company, not merely an announcement of a report's availability. Therefore, it is classified as an Annual Report (10-K). FY 2021
2021-07-13 English
Directorate Change
Board/Management Information Classification · 1% confidence The document is an official announcement from Omega Diagnostics Group PLC regarding a change in the company's board/management, specifically the resignation of the Group Finance Director and the appointment of a new Chief Financial Officer. This falls directly under the definition of Board/Management Information (MANG).
2021-07-13 English
AbC-19 rapid antibody test performance evaluation
Regulatory Filings Classification · 1% confidence The document is a press release distributed via the RNS Reach service regarding a peer-reviewed performance evaluation of a medical product (AbC-19 test). It is a short, non-regulatory announcement that provides highlights of external studies and directs readers to an external link for the full report. As it does not fit into specific financial reporting categories like 10-K, IR, or ER, and serves as a general corporate update/announcement, it is classified as a Regulatory Filing (RNS).
2021-07-09 English
FDA submission for Emergency Use Authorization
Regulatory Filings Classification · 1% confidence The document is a press release issued via the RNS Reach service regarding a company's regulatory submission (FDA Emergency Use Authorization) for a product. It does not fit into specific categories like financial reports, dividends, or director dealings. As it is a general corporate announcement regarding business operations and regulatory progress, it falls under the RNS (Regulatory Filings) category.
2021-07-02 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.